Stryker Hip Replacement Recall and the Recent Settlement Offer

Stryker Hip Replacement Recall and the Recent Settlement Offer

Last Updated: January 30th, 2026

According to the Digital Journal, patients who received Stryker Rejuvenate and Stryker ABG II hip replacements within the past five years may need to have an additional surgery since Stryker recalled these hips.

Roughly, one million people are affected by this massive recall.

Frequently Asked Questions

In 2009 and 2010, Stryker introduced the latest evolution of its hip replacements: the Rejuvenate and the ABG II.

Both hip implants were constructed of cobalt and chromium neckpieces and titanium alloy stems.

The two pieces articulate, or move against each other.

The design of these devices caused metal-on-metal rubbing, which led to them corroding and releasing metal ions in to patients’ bloodstreams and surrounding tissue.

The Digital Journal says studies found that the hip replacements were failing due to “unnecessary friction.” They also concluded that Stryker may have designed the devices poorly by making them loose or too steeply angled to allow for normal flexibility.

Patients began to report high levels of metal in their blood, because tiny fragments from the hips were breaking off and entering their bloodstream.

Due to this, Stryker recalled the defective devices in June 2012.

What is the Settlement for Revision Patients?

Stryker and the Plaintiffs’ Steering Committee in the Stryker modular hip litigation recently announced a settlement offer for Stryker Rejuvenate and AGB II revision patients.

The settlement is uncapped for Stryker and is valued around $1 billion with an estimated 3,000 qualifying patients.

You can find out more details about the settlement and qualifications on our website.

Zoll & Kranz – Defective Medical Drug and Device Lawyers

Zoll & Kranz Note: According to DigitalJournal.com, the Stryker hip replacement recall has affected about one million patients across the world.

Free Consultation

(419) 827-3194

Published by:

Michelle L. Kranz

Michelle is a founding partner of Zoll & Kranz, located in Toledo, Ohio. Michelle has been a plaintiff’s lawyer for the entirety of her practice – over 32 years. She devotes the majority of her time to complex consolidated litigation and class action including advocating for people injured by medical devices, prescription medications, or corporate negligence.

Legally Reviewed

This article has been written and reviewed for legal accuracy and clarity by the team of writers and attorneys at Zoll & Kranz, LLC and is as accurate as possible. This content should not be taken as legal advice from an attorney. If you would like to learn more about our owner and experienced Ohio injury lawyer, Michelle L. Kranz, you can do so here.

Fact-Checked

Zoll & Kranz, LLC does everything possible to make sure the information in this article is up to date and accurate. If you need specific legal advice about your case, contact us. This article should not be taken as advice from an attorney.

Additional Product Liability resources on our website: